Brief: Enlivex Appoints Andrew Singer To Its Board Of Directors
17/04/2023 13:06
April 17 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX APPOINTS ANDREW SINGER TO ITS BOARD OF DIRECTORS
Source text for Eikon: ID:nGNX2knZvT
Further company coverage: ENLV.TA
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment